Skip to main content

Shareholders of Verona Pharma Approve Proposed Acquisition by Merck

Transaction expected to close on October 7, 2025 LONDON, U.K., and RALEIGH, N.C., Sept. 24, 2025 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a biopharmaceutical company focused on respiratory diseases, which entered into a definitive agreement on July 8, 2025 relating to its proposed acquisition by Merck & Co., Inc. (NYSE: MRK) (“Merck”) through a wholly owned subsidiary or a nominee, today announced that its shareholders have approved the proposal for Merck to acquire Verona Pharma for $107 per American Depository Share (ADS), each of which represents eight Verona Pharma ordinary shares, for a total transaction value of approximately $10 billion (the “Transaction”). The Transaction is being implemented by way of a scheme of arrangement under English law (the “Scheme”) and remains subject to the...

Continue reading

North Atlantic France SAS reaches a key milestone in its project to acquire a majority stake in Esso Société Anonyme Française SA and 100% of ExxonMobil Chemical France SAS, with the signing of a share purchase agreement

ST. JOHN’S, NL, CANADA, Sept. 24, 2025 (GLOBE NEWSWIRE) — North Atlantic France SAS reaches a key milestone in its project to acquire a majority stake in Esso Société Anonyme Française SA and 100% of ExxonMobil Chemical France SAS, with the signing of a share purchase agreement ST. JOHN’S, NL, CANADA, September 24, 2025 – North Atlantic France SAS (“North Atlantic”) announced on May 28, 2025, that it had entered into exclusive negotiations with ExxonMobil France Holding SAS (“ExxonMobil”) for the acquisition of ExxonMobil’s entire stake in Esso Société Anonyme Française SA (“Esso S.A.F.”) and ExxonMobil Chemical France SAS by signing a put option agreement. Following the information and consultation process of employees’ representative bodies, North Atlantic today announces that it has entered into an agreement with ExxonMobil...

Continue reading

FINANCIAL PRESS RELEASE : SALE OF HEIDSIECK & CO MONOPOLE

Reims, September 24, 2025 Vranken-Pommery Monopole has entered exclusive negotiations with Lanson-BCC, acting on behalf of its subsidiary Maison Burtin, with a view to selling the shares of Heidsieck & Co Monopole (owner of the eponymous brand), excluding all other assets. Subject to the approval of the Boards of Directors of both companies, the agreement is expected to be signed on October 1, 2025. About Vranken-Pommery Monopole : Vranken-Pommery Monopole manages 2,600 hectares of land, either owned or leased, spread across four vineyards in Champagne, Provence, Camargue, and the Douro. The group is involved in all aspects of winegrowing, from production to marketing, with a strong commitment to promoting terroirs, sustainable viticulture, and environmental preservation. Its brand portfolio includes:The Vranken, Pommery &...

Continue reading

NxGen Brands Finalizes Acquisition of High-Performing Turnkey Business, Citing Significant Untapped Growth Potential

DENVER, Sept. 24, 2025 (GLOBE NEWSWIRE) — NxGen Brands, Inc. (OTC: NXGB) today announced the official closing of its acquisition of a fully operational turnkey business. The new acquisition, operating within an exciting, unique, and ever-growing industry, is already demonstrating remarkable performance that has significantly surpassed initial expectations. This immediate success provides a strong foundation for the company’s strategic growth initiatives, which are poised to unlock even greater value. Analyzing Immediate Performance and Untapped Value The acquisition’s immediate high-level performance serves as a robust validation of its intrinsic value, achieved even before the implementation of NxGen’s strategic enhancements. These initial results highlight a robust operational core and a highly receptive market,...

Continue reading

Amaze to Acquire The Food Channel, Expanding Culinary Creator Network

Amaze’s next-generation e-commerce platform to power The Food Channel into a global food and beverage creator ecosystem NEWPORT BEACH, Calif., Sept. 24, 2025 (GLOBE NEWSWIRE) — Amaze Holdings, Inc. (NYSE American: AMZE) (“Amaze”), a global leader in creator-powered commerce, today announced it has signed a letter of intent to acquire all of the assets of The Food Channel®, a prominent digital platform dedicated to culinary content and inspiration. The companies expect to complete a definitive asset purchase agreement within the coming weeks, at which time The Food Channel will become a wholly owned subsidiary of Amaze Holdings, Inc. The acquisition will allow Amaze to combine its own network of food creators with The Food Channel’s assets to power a next-generation social commerce and entertainment platform. Amaze will provide...

Continue reading

PRS REIT Plc

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: AXA Investment Managers S.A.(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree PRS REIT plc, The(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  (e)   Date position held/dealing undertaken:        For an...

Continue reading

Form 8.3 – [IQE PLC – 23 09 2025] – (CGAML)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree IQE PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

Continue reading

Vox Royalty Announces Agreement to Acquire Transformational Global Gold Portfolio, Overnight Marketed Offering of Common Shares and Expanded Revolving Credit Facility

All figures expressed in USD unless noted otherwise. DENVER, Sept. 23, 2025 (GLOBE NEWSWIRE) — Vox Royalty Corp. (NASDAQ: VOXR) (TSX: VOXR) (“Vox” or the “Company”), a returns focused mining royalty and streaming company, is pleased to announce that it has entered into definitive agreements to acquire a global gold portfolio of ten gold offtake and royalty assets, covering twelve mines and projects across eight jurisdictions, including Australia, Brazil, Canada, Côte d’Ivoire, Mali, Mexico, South Africa and the United States (the “Portfolio”), from certain subsidiaries of Deterra Royalties Limited (“Deterra”), for total upfront cash consideration of $57.5 million and $2.5 million in deferred milestones (the “Transaction”). The Transaction will be funded with a concurrent overnight marketed offering of common shares and an upsized...

Continue reading

Privia Health Expands Value-Based Care Footprint with Acquisition of Accountable Care Organization Business from Evolent Health

ARLINGTON, Va., Sept. 23, 2025 (GLOBE NEWSWIRE) — Privia Health Group, Inc. (Nasdaq: PRVA) announced that it signed a definitive agreement to acquire an Accountable Care Organization (ACO) business from Evolent Health, Inc. (NYSE: EVH). The ACO business cares for over 120,000 attributed lives through the Medicare Shared Savings Program (MSSP), as well as various commercial and Medicare Advantage programs. With this transaction, Privia Health will now serve approximately 1.5 million attributed lives in value-based care (VBC) arrangements across commercial, Medicare, Medicare Advantage and Medicaid. Privia Health will pay $100 million in cash at closing and up to an additional $13 million subject to final MSSP performance for 2025. The transaction is expected to close in the fourth quarter of 2025, and is expected to positively contribute...

Continue reading

QNB Corp. and The Victory Bancorp, Inc. Announce Growth-Focused Strategic Combination

Quakertown, PA, Sept. 23, 2025 (GLOBE NEWSWIRE) — QNB Corp. (“QNB”) (OTCQX: QNBC) and The Victory Bancorp, Inc. (“Victory”) (OTCQX: VTYB), Limerick, Pa, today announced they have entered into a definitive agreement under which QNB will acquire Victory in an all-stock transaction valued at approximately $40.97 million in the aggregate based on QNB’s closing stock price of $35.60 as of September 22, 2025, resulting in an implied price per share to holders of Victory Common Stock of approximately $19.58 per share.  Under the terms of the definitive agreement, which was unanimously approved by the boards of directors of both companies, upon the completion of the merger, Victory shareholders would receive 0.5500 shares of QNB common stock for each share of Victory common stock they own.  Any outstanding Victory...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.